Discovery of a novel DDRs kinase inhibitor XBLJ-13 for the treatment of idiopathic pulmonary fibrosis

Ying Dong(Chinese Academy of Sciences), Yi Zang(Shanghai Institute of Materia Medica)
Acta Pharmacologica Sinica
November 24, 2021
Cited by 15


Related Papers